Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical Features, Survival, and Burden of Toxicities in Survivors More Than One Year After Lung Cancer Immunotherapy.
Hsu ML, Murray JC, Psoter KJ, Zhang J, Barasa D, Brahmer JR, Ettinger DS, Forde PM, Hann CL, Lam VK, Levy B, Marrone KA, Patel T, Peterson V, Sagorsky S, Turner M, Anagnostou V, Naidoo J, Feliciano JL. Hsu ML, et al. Among authors: sagorsky s. Oncologist. 2022 Nov 3;27(11):971-981. doi: 10.1093/oncolo/oyac140. Oncologist. 2022. PMID: 35972337 Free PMC article.
An Oncology Urgent Care Clinic for the Management of Immune-Related Adverse Events: A Descriptive Analysis.
Liang KL, Tackett S, Myers S, Brahmer JR, Browner IS, Ettinger DS, Forde PM, Hales RK, Hann CL, Lam VK, Marrone KA, Patel T, Peterson V, Sagorsky S, Turner M, Voong KR, Naidoo J, Feliciano JL. Liang KL, et al. Among authors: sagorsky s. Curr Oncol. 2022 Jun 17;29(6):4342-4353. doi: 10.3390/curroncol29060347. Curr Oncol. 2022. PMID: 35735456 Free PMC article.
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC).
Brahmer JR, Govindan R, Anders RA, Antonia SJ, Sagorsky S, Davies MJ, Dubinett SM, Ferris A, Gandhi L, Garon EB, Hellmann MD, Hirsch FR, Malik S, Neal JW, Papadimitrakopoulou VA, Rimm DL, Schwartz LH, Sepesi B, Yeap BY, Rizvi NA, Herbst RS. Brahmer JR, et al. Among authors: sagorsky s. J Immunother Cancer. 2018 Jul 17;6(1):75. doi: 10.1186/s40425-018-0382-2. J Immunother Cancer. 2018. PMID: 30012210 Free PMC article.
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma.
Govindan R, Aggarwal C, Antonia SJ, Davies M, Dubinett SM, Ferris A, Forde PM, Garon EB, Goldberg SB, Hassan R, Hellmann MD, Hirsch FR, Johnson ML, Malik S, Morgensztern D, Neal JW, Patel JD, Rimm DL, Sagorsky S, Schwartz LH, Sepesi B, Herbst RS. Govindan R, et al. Among authors: sagorsky s. J Immunother Cancer. 2022 May;10(5):e003956. doi: 10.1136/jitc-2021-003956. J Immunother Cancer. 2022. PMID: 35640927 Free PMC article.